Cytomegalovirus (CMV) Vaccine Study
Now Enrolling in Atlanta, Austin, Beaumont, Edmond, Fort Collins, San Antonio, and Yukon
CMV Investigational Vaccine Study
Tekton Research is looking for women (16-40) to participate in a clinical trial.
You may be eligible to take part if you are:
- A woman 16-40 years of age.
- In good health.
- In close contact with at least 1 child 5 years or younger at least 8 hours a week, if age 20 or older.
- NOT pregnant or planning on becoming pregnant in the next 9 months.
What is CMV?
Cytomegalovirus (CMV) is a leading cause of birth defects around the world and is the number one infection that causes birth defects in the U.S.
CMV is a common viral infection that usually goes unnoticed or only causes mild symptoms in most people. Currently, there is no approved vaccine against this devastating virus.
Why Tekton?
Tekton Research is a clinical research site that conducts clinical studies with the primary focus on improving the quality of life for all.
We work with pharmaceutical and device companies to help bring new and more effective medications to those who need them. We conduct studies with deliberate concentration on knowledge, skills and integrity.
Here at Tekton, our staff ensures that every potential and current study participant is accurately qualified for the most appropriate study based on criteria.
